Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.75
Bid: 17.00
Ask: 18.50
Change: 4.00 (29.09%)
Spread: 1.50 (8.824%)
Open: 16.25
High: 18.25
Low: 15.25
Prev. Close: 13.75
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Jefferies cuts Berkeley, Barratt and Bellway

Mon, 24th Jan 2022 09:36

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

BOFA RAISES HARGREAVES LANDSDOWN TO 'BUY' (NEUTRAL) - PRICE TARGET 1,625 (1,475) PENCE

----------

UBS CUTS PEARSON TO 'SELL' (NEUTRAL) - PRICE TARGET 620 PENCE

----------

STIFEL RAISES BURBERRY PRICE TARGET TO 2,300 (2,250) PENCE - 'BUY'

----------

BERENBERG RAISES SAINSBURY(J) PRICE TARGET TO 285 (275) PENCE - 'HOLD'

----------

RBC CUTS ANTOFAGASTA PRICE TARGET TO 1,400 (1,450) PENCE - 'SECTOR PERFORM'

----------

HSBC CUTS HALMA TO 'REDUCE'

----------

RBC CUTS AB FOODS TO 'SECTOR PERFORM' (OUTPERFORM) - PRICE TARGET 2,250 PENCE

----------

GOLDMAN SACHS CUTS ENTAIN PRICE TARGET TO 2,250 (2,300) PENCE - 'BUY'

----------

JEFFERIES CUTS TAYLOR WIMPEY PRICE TARGET TO 202 (229) PENCE - 'BUY'

----------

JEFFERIES CUTS PERSIMMON PRICE TARGET TO 3,264 (3,604) PENCE - 'BUY'

----------

JEFFERIES CUTS BERKELEY GROUP TO 'HOLD' (BUY) - PRICE TARGET 4,703 (6,212) PENCE

----------

JEFFERIES CUTS BARRATT DEVELOPMENTS TO 'HOLD' (BUY) - PRICE TARGET 644 (851) PENCE

----------

FTSE 250

----------

DAVY RAISES EASYJET TO 'OUTPERFORM' (NEUTRAL)

----------

BARCLAYS RAISES ULTRA ELECTRONICS TARGET TO 2,350 (2,200) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES TRAVIS PERKINS TARGET TO 1,545 (1,375) PENCE - 'EQUAL WEIGHT'

----------

DEUTSCHE BANK RAISES JUST GROUP PRICE TARGET TO 113 (105) PENCE - 'HOLD'

----------

BERENBERG RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 760 (730) PENCE - 'BUY'

----------

BERENBERG RAISES HISCOX PRICE TARGET TO 1,045 (970) PENCE - 'HOLD'

----------

BERENBERG RAISES BEAZLEY PRICE TARGET TO 600 (490) PENCE - 'BUY'

----------

GOLDMAN RAISES WATCHES OF SWITZERLAND TARGET TO 1,240 (1,205) PENCE - 'NEUTRAL'

----------

JPMORGAN CUTS HOCHSCHILD MINING PRICE TARGET TO 190 (200) PENCE - 'OVERWEIGHT'

----------

JEFFERIES CUTS VISTRY PRICE TARGET TO 1,345 (1,513) PENCE - 'BUY'

----------

JEFFERIES CUTS REDROW PRICE TARGET TO 796 (942) PENCE - 'BUY'

----------

JEFFERIES CUTS CREST NICHOLSON PRICE TARGET TO 433 (506) PENCE - 'BUY'

----------

JEFFERIES CUTS COUNTRYSIDE PROPERTIES PRICE TARGET TO 494 (566) PENCE - 'BUY'

----------

JEFFERIES CUTS BELLWAY TO 'HOLD' (BUY) - PRICE TARGET 3,339 (4,187) PENCE

----------

SMALL CAP

----------

BERENBERG RAISES CONDUIT HOLDINGS PRICE TARGET TO 640 (620) PENCE - 'BUY'

----------

RBC CUTS SUPERDRY PRICE TARGET TO 415 (425) PENCE - 'OUTPERFORM'

----------

BERENBERG INITIATES ANGLE WITH 'BUY' - TARGET 195 PENCE

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
Today 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
Today 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
Today 10:52

AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

Read more
Today 08:48

LONDON MARKET OPEN: Confident start before US jobs data

(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling some hawkish Federal Reserve interest rate expectations.

Read more
Today 07:58

Angle strikes supplier deal with AstraZeneca

(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen receptor detection assay to enhance prostate cancer studies.

Read more
Today 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
24 Apr 2024 17:06

CORRECT: No record close for FTSE 100; mixed trade in US

(Correcting day of the week in the opening sentence.)

Read more
24 Apr 2024 17:00

LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US

(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting another record high.

Read more
24 Apr 2024 10:32

Angle shares jump on supplier agreement with with AstraZeneca

(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.

Read more
24 Apr 2024 10:10

AIM WINNERS & LOSERS: Filtronic jumps as lifts outlook

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
22 Apr 2024 16:52

IN BRIEF: Angle granted patents in US and Europe for Cellkeep slide

Angle PLC - Surrey-based medical diagnostics provider - Says it has been granted a European and US patent for its CellKeep slide. "We are delighted to have secured intellectual property rights for our proprietary CellKeep slide in two major jurisdictions....This is a significant technology advancement for the [circulating tumor cell] liquid biopsy field and another step towards enabling biomarker-guided precision medicine for people with cancer," says Chief Executive Officer Andrew Newland. The CellKeep slide was developed by Angle to reduce cell loss during the transfer of CTCs to the microscope slide and to protect the morphology of the harvested cells.

Read more
22 Apr 2024 06:59

Angle granted European patent for CellKeep, US patent imminent

(Sharecast News) - Liquid biopsy specialist Angle announced on Monday that it has received a European patent for its 'CellKeep' slide, as it anticipated the imminent grant of an equivalent US patent application.

Read more
22 Jan 2024 18:03

IN BRIEF: Angle highlights supportive data for DNA analysis tool

Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.

Read more
4 Jan 2024 16:54

LONDON MARKET CLOSE: Stocks up ahead of US nonfarm payrolls

(Alliance News) - Stock prices in London closed higher on Thursday, as investors eye the latest US non-farms data.

Read more
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.